Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, ORIC Pharmaceuticals Inc’s stock clocked out at $10.98, up 3.10% from its previous closing price of $10.65. In other words, the price has increased by $3.10 from its previous closing price. On the day, 1.04 million shares were traded. ORIC stock price reached its highest trading level at $11.055 during the session, while it also had its lowest trading level at $10.57.
Ratios:
To gain a deeper understanding of ORIC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.65 and its Current Ratio is at 14.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Evercore ISI on November 20, 2025, initiated with a Outperform rating and assigned the stock a target price of $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1069334272 and an Enterprise Value of 789589312.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.34, which has changed by 0.11401677 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -11.40%, while the 200-Day Moving Average is calculated to be 17.44%.
Shares Statistics:
It appears that ORIC traded 1.36M shares on average per day over the past three months and 1262070 shares per day over the past ten days. A total of 97.28M shares are outstanding, with a floating share count of 54.16M. Insiders hold about 44.39% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for ORIC as of 1763078400 were 16253539 with a Short Ratio of 11.96, compared to 1760486400 on 13020257. Therefore, it implies a Short% of Shares Outstanding of 16253539 and a Short% of Float of 16.900000000000002.
Earnings Estimates
The dynamic stock of ORIC Pharmaceuticals Inc (ORIC) is currently attracting attention from 12.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.3 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.48 and -$2.41 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$1.63, with 12.0 analysts recommending between -$1.22 and -$2.54.
